Related Experiment Video
Updated: Jul 16, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention
Jin-Chuan Yan1, Shu Ding, Yi Liang
1Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China. yanjinchuan@hotmail.com
Insights
Elevated CD40 ligand levels are linked to restenosis after percutaneous coronary intervention (PCI), suggesting inflammation plays a role in this cardiovascular complication.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Inflammation Research
Background:
- Percutaneous coronary intervention (PCI) is a common procedure to treat coronary artery disease.
- Restenosis, the re-narrowing of arteries after PCI, remains a significant clinical challenge.
- The CD40-CD40 ligand pathway is implicated in inflammatory processes.
Purpose of the Study:
- To investigate the association between the CD40-CD40 ligand system and restenosis post-PCI.
- To determine if increased expression of CD40 and CD40 ligand correlates with restenosis development.
Main Methods:
- Studied 120 patients undergoing PCI and 20 controls.
- Analyzed platelet CD40 and CD40 ligand (CD40L) expression via flow cytometry.
- Measured serum soluble CD40L (sCD40L) and C-reactive protein (CRP) using ELISA.
- Monitored restenosis over a 6-month follow-up period.
Main Results:
- Restenosis occurred in 24.2% of patients.
- Patients with restenosis exhibited higher pre-PCI CD40-CD40L system levels.
- Significantly elevated platelet CD40, CD40L, and serum sCD40L were observed in restenotic patients post-PCI.
- Elevated sCD40L and CD40L correlated with CRP levels and lumen loss.
Conclusions:
- CD40 ligand levels are associated with late restenosis after PCI.
- These findings indicate that restenosis is an inflammatory disorder.
- Targeting the CD40-CD40 ligand pathway may offer therapeutic potential for preventing restenosis.
Aim:
To investigate whether the increasing CD40-CD40 ligand system is related to restenosis in patients after percutaneous coronary intervention (PCI).
Methods:
Twenty normal controls and 120 patients with PCI were investigated. The expression of CD40 and the CD40 ligand (CD40L) on platelets was analyzed by indirectimmunofluorescence flow cytometry. The serum level of soluble CD40L (sCD40L) and C-reactive protein (CRP) was determined by commercially available enzyme linked immunosorbent assay. Restenosis was observed in 120 patients within a 6 month follow-up period after PCI surgery.
Results:
Restenosis occurred in 29 patients (24.2%). Patients who developed restenosis showed higher levels of CD40-CD40L system compared with non-restenotic patients before PCI. All restenotic patients showed a significant increase in CD40 [66.9 +/-4.8, mean fluorescence intensity (MFI)] and CD40L (14.9 +/-1.8, MFI) co-expression on platelets as well as sCD40L (13.7 +/-1.7 ng/mL) compared with non-restenotic patients and controls during the 6 month follow-up period (P<0.01). Elevated sCD40L and CD40L were significantly correlated with the serum level of CRP after percutaneous transluminal coronary angioplasty and with lumen loss during the 6 month followup period.
Conclusion:
The level of CD40L was associated with late restenosis after PCI indicating that restenosis is an inflammatory disorder.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
01:27Peripheral Artery Disease III: Interprofessional Care